--- title: "New Ray Medicine International Holding (6108) stock" url: "https://aibio.space/companies/new-ray-medicine-international/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "New Ray Medicine International Holding Ltd. (HKEX: 6108), China. The directory classifies it as Pharmaceuticals: Major." --- 6108 New Ray Medicine International Holding Ltd. HKEX · China # New Ray Medicine International Holding (6108) news New Ray Medicine International Holding Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6108, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest New Ray Medicine International Holding news We have not published a story on New Ray Medicine International Holding yet. When there is news, it will appear here. ## New Ray Medicine International Holding at a glance - **Ticker**: 6108 - **Listing**: HKEX - **Country**: China ### Related companies - [Jinhe Biotechnology Co.](https://aibio.space/companies/jinhe-biotechnology/) SZSE: 002688 - [Hygeia Healthcare Holdings Co.](https://aibio.space/companies/hygeia-healthcare/) HKEX: 6078 - [China Resources Boya Bio-pharmaceutical Group Co.](https://aibio.space/companies/china-resources-boya-bio-pharmaceutical/) SZSE: 300294 - [Hybio Pharmaceutical Co.](https://aibio.space/companies/hybio-pharmaceutical/) SZSE: 300199 - [Lepu Biopharma Co.](https://aibio.space/companies/lepu-biopharma/) HKEX: 2157 - [Zhejiang Hisun Pharmaceutical Co.](https://aibio.space/companies/zhejiang-hisun-pharmaceutical/) SSE: 600267 - [Mabwell (Shanghai) Bioscience Co.](https://aibio.space/companies/mabwell-shanghai-bioscience/) SSE: 688062 - [Zhong Zhu Healthcare Holding Co.](https://aibio.space/companies/zhong-zhu-healthcare/) SSE: 600568 ### Also on HKEX - [Consun Pharmaceutical Group](https://aibio.space/companies/consun-pharmaceutical/) 1681 - [Zhaoke Ophthalmology](https://aibio.space/companies/zhaoke-ophthalmology/) 6622 - [Jilin Province Huinan Changlong Bio Pharmacy Co.](https://aibio.space/companies/jilin-province-huinan-changlong-bio-pharmacy/) 8049 - [Keymed Biosciences](https://aibio.space/companies/keymed-biosciences/) 2162 - [PuraPharm Corp.](https://aibio.space/companies/purapharm/) 1498 - [Shenzhen Neptunus Interlong Bio-Technique Co.](https://aibio.space/companies/shenzhen-neptunus-interlong-bio-technique/) 8329 ## Questions about New Ray Medicine International Holding What is the ticker symbol of New Ray Medicine International Holding? New Ray Medicine International Holding Ltd. trades under the ticker 6108 on HKEX. Where is New Ray Medicine International Holding listed? New Ray Medicine International Holding Ltd. is listed on HKEX. Which country or territory is New Ray Medicine International Holding listed under? Our directory records New Ray Medicine International Holding Ltd. under China. What does New Ray Medicine International Holding do? Our directory classifies New Ray Medicine International Holding Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of New Ray Medicine International Holding? The ISIN recorded for New Ray Medicine International Holding Ltd. is BMG647461372. Does aibio.space cover New Ray Medicine International Holding? aibio.space lists New Ray Medicine International Holding Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to New Ray Medicine International Holding? Companies in our directory listed in the same country and business area as New Ray Medicine International Holding: Jinhe Biotechnology Co., Hygeia Healthcare Holdings Co., China Resources Boya Bio-pharmaceutical Group Co., Hybio Pharmaceutical Co., Lepu Biopharma Co., Zhejiang Hisun Pharmaceutical Co.. ## Investor discussion: New Ray Medicine International Holding Members talk about New Ray Medicine International Holding (6108). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at New Ray Medicine International Holding, newest first. Each line links the filing it comes from. 1. 2026-10-20 Listings Share consolidation: CHANGE IN BOARD LOT SIZE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1020/2026102001287.pdf) 2. 2026-04-27 Financings Share or debt issue: (1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED ADOPTION OF NEW BYE-LAWS; AND (4) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042702830.pdf) 3. 2025-12-23 Financings Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1223/2025122301288.pdf) 4. 2025-12-05 Financings Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1205/2025120501443.pdf) 5. 2025-08-12 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - COOPERATION AGREEMENT AND ESTABLISHMENT OF THE TARGET COMPANY. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081201296.pdf) 6. 2025-08-06 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - DISPOSAL OF LISTED SECURITIES. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0806/2025080602020.pdf) 7. 2025-06-06 Listings Share consolidation: PROPOSED CAPITAL REORGANISATION. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0606/2025060601483.pdf) 8. 2025-04-24 Financings Share or debt issue: (1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED ADOPTION OF NEW BYE-LAWS; AND (4) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0424/2025042402922.pdf) ## Press releases Headlines of New Ray Medicine International Holding's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-20 HKEXnews [CHANGE IN BOARD LOT SIZE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1020/2026102001287.pdf) 2. 2026-10-12 HKEXnews [RESIGNATION OF EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1012/2026101201095.pdf) 3. 2026-09-04 HKEXnews [2025 ANNUAL REPORT - SUPPLEMENTAL INFORMATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0904/2026090402281.pdf) 4. 2026-08-27 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0827/2026082701619.pdf) 5. 2026-06-18 HKEXnews [THIRD AMENDED AND RESTATED BYE-LAWS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061801618.pdf) 6. 2026-06-18 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 18 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061801604.pdf) 7. 2026-04-27 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042702852.pdf) 8. 2026-04-27 HKEXnews [(1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED ADOPTION OF NEW BYE-LAWS; AND (4) NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042702830.pdf) 9. 2026-04-27 HKEXnews [PROPOSED ADOPTION OF NEW BYE-LAWS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042702792.pdf) 10. 2026-03-25 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032502073.pdf) 11. 2025-12-23 HKEXnews [COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1223/2025122301288.pdf) 12. 2025-12-05 HKEXnews [PLACING OF NEW SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1205/2025120501443.pdf) 13. 2025-10-16 HKEXnews [2024 ANNUAL REPORT - SUPPLEMENTAL INFORMATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1016/2025101601010.pdf) 14. 2025-08-27 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082701859.pdf) 15. 2025-08-12 HKEXnews [DISCLOSEABLE TRANSACTION - COOPERATION AGREEMENT AND ESTABLISHMENT OF THE TARGET COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081201296.pdf) 16. 2025-08-06 HKEXnews [DISCLOSEABLE TRANSACTION - DISPOSAL OF LISTED SECURITIES](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0806/2025080602020.pdf) 17. 2025-07-18 HKEXnews [(1) POLL RESULTS OF THE SPECIAL GENERAL MEETING HELD ON 18 JULY 2025; (2) EFFECTIVE DATE OF THE CAPITAL REORGANISATION; AND (3) ADJUSTMENTS TO THE SHARE OPTIONS](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0718/2025071801158.pdf) 18. 2025-06-30 HKEXnews [TERMS OF REFERENCE OF THE NOMINATION COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0630/2025063003592.pdf) 19. 2025-06-26 HKEXnews [Notification Letter and Request Form to Non-Registered Shareholders](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0626/2025062601762.pdf) 20. 2025-06-26 HKEXnews [Notification Letter and Reply Form to Registered Shareholders](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0626/2025062601754.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:6108 on TradingView](https://www.tradingview.com/symbols/HKEX-6108/). ## Listing details New Ray Medicine International Holding Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6108, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: New Ray Medicine International Holding Ltd. - **Ticker**: 6108 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: BMG647461372 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-6108/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/new-ray-medicine-international/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "New Ray Medicine International Holding (6108) stock", 2026-10-31, https://aibio.space/companies/new-ray-medicine-international/